GMS (GMS) Earns Neutral Rating from Nomura

Share on StockTwits

Nomura restated their neutral rating on shares of GMS (NYSE:GMS) in a research report sent to investors on Thursday morning, BenzingaRatingsTable reports. The brokerage currently has a $20.00 target price on the stock, down from their previous target price of $27.00.

A number of other research firms have also recently weighed in on GMS. TheStreet upgraded GMS from a d+ rating to a c- rating in a report on Thursday, May 2nd. ValuEngine cut GMS from a sell rating to a strong sell rating in a research note on Monday, February 4th. Finally, Zacks Investment Research lowered GMS from a hold rating to a sell rating in a research report on Thursday, March 7th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and six have issued a buy rating to the company. The company has an average rating of Hold and a consensus price target of $24.44.

GMS traded down $0.11 on Thursday, reaching $18.82. 15,001 shares of the company’s stock were exchanged, compared to its average volume of 957,171. The company has a market cap of $765.91 million, a PE ratio of 9.42, a price-to-earnings-growth ratio of 0.87 and a beta of 2.41. GMS has a twelve month low of $13.61 and a twelve month high of $31.53. The company has a debt-to-equity ratio of 1.88, a quick ratio of 1.76 and a current ratio of 2.85.

GMS (NYSE:GMS) last posted its earnings results on Tuesday, March 5th. The company reported $0.41 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.54 by ($0.13). The business had revenue of $723.90 million for the quarter, compared to analyst estimates of $741.43 million. GMS had a return on equity of 18.49% and a net margin of 1.66%. The firm’s revenue for the quarter was up 23.6% compared to the same quarter last year. During the same period last year, the company posted $0.47 EPS. On average, sell-side analysts predict that GMS will post 2.84 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently modified their holdings of the business. FMR LLC increased its holdings in shares of GMS by 27.6% during the first quarter. FMR LLC now owns 1,568,460 shares of the company’s stock valued at $23,715,000 after purchasing an additional 338,959 shares during the period. Geode Capital Management LLC increased its holdings in shares of GMS by 9.0% during the first quarter. Geode Capital Management LLC now owns 391,130 shares of the company’s stock valued at $5,913,000 after purchasing an additional 32,261 shares during the period. Charles Schwab Investment Management Inc. increased its holdings in shares of GMS by 25.0% during the first quarter. Charles Schwab Investment Management Inc. now owns 338,240 shares of the company’s stock valued at $5,115,000 after purchasing an additional 67,626 shares during the period. Cooper Creek Partners Management LLC acquired a new position in shares of GMS during the first quarter valued at $1,728,000. Finally, Formula Growth Ltd. increased its holdings in shares of GMS by 18.6% during the first quarter. Formula Growth Ltd. now owns 795,640 shares of the company’s stock valued at $12,030,000 after purchasing an additional 125,000 shares during the period. 74.55% of the stock is currently owned by hedge funds and other institutional investors.

About GMS

GMS Inc distributes wallboards, suspended ceilings systems, and related construction products in the United States and Canada. The company offers wallboard products; and ceilings products, including suspended mineral fibers, soft fibers, and metal ceiling systems primarily used in offices, hotels, hospitals, retail facilities, schools, and various other commercial and institutional buildings.

Featured Article: Asset Allocation and Your Retirement

Analyst Recommendations for GMS (NYSE:GMS)

Receive News & Ratings for GMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMS and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Eros International  Issues Quarterly  Earnings Results
Eros International Issues Quarterly Earnings Results
OrganiGram  Announces Quarterly  Earnings Results
OrganiGram Announces Quarterly Earnings Results
Brokerages Set Matador Resources Co  Price Target at $31.58
Brokerages Set Matador Resources Co Price Target at $31.58
ProAssurance Co.  Receives $41.75 Consensus Price Target from Brokerages
ProAssurance Co. Receives $41.75 Consensus Price Target from Brokerages
Zacks: Can-Fite Biopharma Ltd  Receives Average Rating of “Strong Buy” from Analysts
Zacks: Can-Fite Biopharma Ltd Receives Average Rating of “Strong Buy” from Analysts
Flowers Foods, Inc.  Expected to Announce Earnings of $0.26 Per Share
Flowers Foods, Inc. Expected to Announce Earnings of $0.26 Per Share


© 2006-2019 Ticker Report